Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bempt IV"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bempt IV, Loo PV, Drijkoningen M, Neven P, Smeets A, Christiaens M, Paridaens R, De Wolf-Peeters C
Publikováno v:
Journal of Clinical Oncology; 10/20/2008, Vol. 26 Issue 30, p4869-4874, 6p
Autor:
Freiberger SN; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Ikenberg K; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., van Egmond D; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Claerhout S; Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium., van Wezel T; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Bempt IV; Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium., van Rossem JN; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Mueller SA; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland., Clement PM; Department of Oncology, Section Experimental Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Poorten VV; Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Department of Oncology, Section Head and Neck Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Cohen D; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Hauben E; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Publikováno v:
Cancer cytopathology [Cancer Cytopathol] 2024 Jul; Vol. 132 (7), pp. 435-446. Date of Electronic Publication: 2024 Apr 02.
Autor:
Koshyk O; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Czech Republic; Medical Laboratory CSD, Ltd, Kyiv, Ukraine., Dehner CA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana., van den Hout MFCM; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Bempt IV; Department for Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Sciot R; Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Huang HY; Department of Anatomical Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, Taiwan., Agaimy A; Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany., Din NU; Section of Histopathology, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan., Klubíčková N; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Czech Republic; Bioptical Laboratory, Ltd, Plzeň, Czech Republic., Mosaieby E; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Czech Republic; Bioptical Laboratory, Ltd, Plzeň, Czech Republic., Skálová A; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Czech Republic; Bioptical Laboratory, Ltd, Plzeň, Czech Republic., Michalová K; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Czech Republic; Bioptical Laboratory, Ltd, Plzeň, Czech Republic., Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of Oncology, KU Leuven, Laboratory of Experimental Oncology, Leuven, Belgium., Oliveira AM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Halling KC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Gupta S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Gross JM; Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland., Nin JWM; Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands., Michal M; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Czech Republic; Bioptical Laboratory, Ltd, Plzeň, Czech Republic., Folpe AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kosemehmetoglu K; Department of Pathology, Hacettepe University, Ankara, Turkey., Torres-Mora J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Michal M; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Czech Republic; Bioptical Laboratory, Ltd, Plzeň, Czech Republic. Electronic address: michael.michal@biopticka.cz.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2023 Dec; Vol. 36 (12), pp. 100337. Date of Electronic Publication: 2023 Sep 22.
Autor:
Renier R; KU Leuven, Department of Dermatology, Leuven, Belgium., De Haes P; KU Leuven, Department of Pathology, Leuven, Belgium., Bosisio F; KU Leuven, Department of Pathology, Leuven, Belgium., Bempt IV; KU Leuven, Department of Human Genetics, Leuven, Belgium., Woei-A-Jin FJSH; KU Leuven, University Hospitals Leuven, Department of General Medical Oncology, Leuven, Belgium.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2023 Apr 23; Vol. 36, pp. 78-81. Date of Electronic Publication: 2023 Apr 23 (Print Publication: 2023).
Autor:
Thouvenin J; Hospices Civils de Lyon, Medical Oncology, Lyon, France; Institut Jules Bordet, Medical Oncology Clinic, Brussels, Belgium., Van Marcke C; UCLouvain, Ottignies-Louvain-la-Neuve, Belgium., Decoster L; UZ Brussel, Medical Oncology, Brussels, Belgium., Raicevic G; Sciensano, Brussels, Belgium., Punie K; KU Leuven University Hospitals Leuven, General Medical Oncology, Leuven, Belgium., Vandenbulcke M; Sciensano, Brussels, Belgium., Salgado R; GasthuisZusters Antwerpen, Pathology, Antwerp, Belgium., Van Valckenborgh E; Sciensano, Brussels, Belgium., Maes B; Laboratory of Molecular Diagnostics, Jessa Hospital Campus Virga Jesse, Hasselt, Belgium., Joris S; UZ Brussel, Medical Oncology, Brussels, Belgium., Steichel DV; Fondation contre le Cancer, Schaerbeek, Belgium., Vranken K; Pediatric Oncology, WIV-ISP, Leuven, Belgium., Jacobs S; KU Leuven Hospital, Leuven., Dedeurwaerdere F; Laboratory of Pathology, AZ Delta, Roeselare, Belgium., Martens G; Laboratoriumgeneeskunde, AZ Delta, Roeselare, Belgium., Devos H; Laboratoriumgeneeskunde, AZ Sint-Jan, Bruges, Belgium., Duhoux FP; UCLouvain, Ottignies-Louvain-la-Neuve, Belgium., Rasschaert M; Universitair Ziekenhuis Antwerpen, Medical Oncology, Antwerpen, Belgium; Medical Oncology, AZ Monica, Deurne, Belgium., Pauwels P; Universitair Ziekenhuis Antwerpen, Pathology, Antwerpen, Belgium., Geboes K; Division of Digestive Oncology, Department of Gastroenterology, UZ Gent, Gent, Belgium; Department of Internal Medicine and Pediatrics, UZ Gent, Gent, Belgium., Collignon J; Medical Oncology, CHU de Liege - Hospital Sart Tilman, Liège, Belgium., Tejpar S; KU Leuven Hospital, Leuven., Canon JL; Grand Hôpital de Charleroi Site Notre Dame, Service d'Oncologie-Hématologie, Charleroi, Belgium., Peeters M; Universitair Ziekenhuis Antwerpen, Oncology, Antwerpen, Belgium., Rutten A; GZA Ziekenhuizen Campus Sint-Vincentius, Medical Oncology, Antwerpen, Belgium., Van de Mooter T; GZA Ziekenhuizen Campus Sint-Vincentius, Medical Oncology, Antwerpen, Belgium., Vermeij J; ZNA Middelheim, Medical Oncology, Antwerpen, Belgium., Schrijvers D; ZNA, Antwerpen, Belgium., Demey W; AZ Klina, Medical Oncology, Brasschaat, Belgium., Lybaert W; GZA Ziekenhuizen Campus Sint-Vincentius, Medical Oncology, Antwerpen, Belgium., Van Huysse J; AZ Sint-Jan Brugge-Oostende, Pathology, Brugge, Belgium., Mebis J; Laboratory of Molecular Diagnostics, Jessa Hospital Campus Virga Jesse, Hasselt, Belgium., Awada A; Institut Jules Bordet, Medical Oncology Clinic, Anderlecht, Belgium., Claes KBM; UGent, Gent, Belgium., Hebrant A; Sciensano, Brussels, Belgium., Van der Meulen J; UGent, Gent, Belgium., Delafontaine B; UZ Gent, Gent, Belgium., Bempt IV; KU Leuven Hospital, Leuven, Belgium., Maetens J; Sciensano, Brussels, Belgium., de Hemptinne M; Sciensano, Brussels, Belgium., Rottey S; Medical Oncology Department, UZ Gent, Gent, Belgium., Aftimos P; Institut Jules Bordet, Medical Oncology Clinic, Anderlecht, Belgium., De Grève J; UZ Brussel, Medical Oncology, Brussels, Belgium. Electronic address: Jacques.degreve@uzbrussel.be.
Publikováno v:
ESMO open [ESMO Open] 2022 Aug; Vol. 7 (4), pp. 100524. Date of Electronic Publication: 2022 Aug 12.
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma.
Autor:
Marin-Bejar O; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Rogiers A; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Dewaele M; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Femel J; Ronald O. Perelman Department of Dermatology and Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA., Karras P; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Pozniak J; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Bervoets G; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Van Raemdonck N; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Pedri D; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Swings T; VIB Technology Watch, Technology Innovation Lab, VIB, Leuven, Belgium., Demeulemeester J; Laboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven, Belgium; Cancer Genomic Laboratory, The Francis Crick Institute, London, UK., Borght SV; Department of Pathology, UZ Leuven, Leuven, Belgium., Lehnert S; Center for Human Genetics, KULeuven, Leuven, Belgium., Bosisio F; Laboratory of Translational Cell and Tissue Research, Department of Pathology, KU Leuven and UZ Leuven, Leuven, Belgium., van den Oord JJ; Laboratory of Translational Cell and Tissue Research, Department of Pathology, KU Leuven and UZ Leuven, Leuven, Belgium., Bempt IV; Center for Human Genetics, KULeuven, Leuven, Belgium., Lambrechts D; Laboratory of Translational Genetics, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory of Translational Genetics, Center for Human Genetics, KU Leuven, Belgium., Voet T; Laboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven, Belgium; KU Leuven Institute for Single Cell Omics, LISCO, KU Leuven, Leuven, Belgium., Bechter O; Department of General Medical Oncology UZ Leuven, Belgium., Rizos H; Macquarie University, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia., Levesque MP; Department of Dermatology, University of Zürich Hospital, University of Zürich, Zürich, Switzerland., Leucci E; Laboratory for RNA Cancer Biology, Department of Oncology, LKI, KU Leuven, Leuven, Belgium; Trace PDX Platform, Department of Oncology, LKI, KU Leuven, Leuven, Belgium., Lund AW; Ronald O. Perelman Department of Dermatology and Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA., Rambow F; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: florian.rambow@kuleuven.be., Marine JC; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: jeanchristophe.marine@kuleuven.be.
Publikováno v:
Cancer cell [Cancer Cell] 2021 Aug 09; Vol. 39 (8), pp. 1135-1149.e8. Date of Electronic Publication: 2021 Jun 17.
Autor:
Lenaerts L; Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium., Brison N; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium., Maggen C; Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium., Vancoillie L; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium., Che H; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium., Vandenberghe P; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium.; Hematology, University Hospitals Leuven, Herestraat 49, Leuven, Belgium., Dierickx D; Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Hematology, University Hospitals Leuven, Herestraat 49, Leuven, Belgium., Michaux L; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium., Dewaele B; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium., Neven P; Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Gynaecology and Obstetrics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium., Floris G; Pathology, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Imaging & Pathology, KU Leuven, Herestraat 49, Leuven, Belgium., Tousseyn T; Pathology, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Imaging & Pathology, KU Leuven, Herestraat 49, Leuven, Belgium., Lannoo L; Gynaecology and Obstetrics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Department of Development and Regeneration, KU Leuven, Herestraat 49, Leuven, Belgium., Jatsenko T; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium., Bempt IV; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium., Van Calsteren K; Gynaecology and Obstetrics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Department of Development and Regeneration, KU Leuven, Herestraat 49, Leuven, Belgium., Vandecaveye V; Radiology, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Imaging & Pathology, KU Leuven, Herestraat 49, Leuven, Belgium., Dehaspe L; Genomics Core facility, KU Leuven, Herestraat 49, Leuven, Belgium., Devriendt K; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium., Legius E; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium., Bogaert KVD; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium., Vermeesch JR; Center for Human Genetics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Department of Human Genetics, KU Leuven, Herestraat 49, Leuven, Belgium.; Genomics Core facility, KU Leuven, Herestraat 49, Leuven, Belgium., Amant F; Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Gynaecology and Obstetrics, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Academic Medical Centers Amsterdam-University of Amsterdam and The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2021 May 13; Vol. 35, pp. 100856. Date of Electronic Publication: 2021 May 13 (Print Publication: 2021).
Autor:
Libbrecht L; Department of Pathology, University Hospital Saint-Luc, Brussels, Belgium. Electronic address: louis.libbrecht@uclouvain.be., Bempt IV; Centre for Human Genetics, University Hospitals Leuven, Leuven, Belgium., Schubert T; Department of Orthopedic Surgery, University Hospital Saint-Luc, Brussels, Belgium., Sciot R; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Galant C; Department of Pathology, University Hospital Saint-Luc, Brussels, Belgium.
Publikováno v:
Annals of diagnostic pathology [Ann Diagn Pathol] 2019 Dec; Vol. 43, pp. 151409. Date of Electronic Publication: 2019 Oct 05.
Autor:
Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Claes B; Biocartis NV, 2800 Mechelen, Belgium., Huang HJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Falchook GS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Sarah Cannon Research Institute at HealthONE, Denver, CO 80218, USA., Devogelaere B; Biocartis NV, 2800 Mechelen, Belgium.; Cartagenia, 3001 Leuven, Belgium., Kockx M; HistoGeneX NV, 2600 Berchem, Belgium., Bempt IV; HistoGeneX NV, 2600 Berchem, Belgium., Reijans M; Biocartis NV, 2800 Mechelen, Belgium., Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Holley VR; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Stepanek VM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kopetz ES; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wheler JJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zinner RG; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Karp DD; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Luthra R; Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sablon E; Biocartis NV, 2800 Mechelen, Belgium., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Maertens G; Biocartis NV, 2800 Mechelen, Belgium., Kurzrock R; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, La Jolla, CA 92093, USA.
Publikováno v:
Oncotarget [Oncotarget] 2015 Sep 29; Vol. 6 (29), pp. 26886-94.